Prediction of adjuvant chemotherapy response in triple negative breast cancer with discovery and targeted proteomics.

Prediction of adjuvant chemotherapy response in triple negative breast cancer with discovery and targeted proteomics.

Triple-negative breast cancer (TNBC) accounts for 15-20% of all breast cancers and usually requires the administration of adjuvant chemotherapy after surgery but even with this treatment many patients still suffer from a relapse. The main objective of this study was to identify proteomics-based biom...

Full description

Bibliographic Details
Main Authors: Angelo Gámez-Pozo, Lucía Trilla-Fuertes, Guillermo Prado-Vázquez, Cristina Chiva, Rocío López-Vacas, Paolo Nanni, Julia Berges-Soria, Jonas Grossmann, Mariana Díaz-Almirón, Eva Ciruelos, Eduard Sabidó, Enrique Espinosa, Juan Ángel Fresno Vara
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5464546?pdf=render

Internet

http://europepmc.org/articles/PMC5464546?pdf=render

Similar Items